CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer

Citation

Sanij, E, Hannan, K, Xuan, J et al. 2020, 'CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer', Nature Communications, vol. 11, no. 1, pp. -.

Year

2020

ANU Authors

Updated:  01 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers